Efficacy of Tenecteplase vs Alteplase in Patients With Acute Ischaemic Cerebrovascular Events
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tenecteplase versus alteplase in acute ischaemic cerebrovascular events (TRACE-2): a phase 3, multicentre, open-label, randomised controlled, non-inferiority trial
Lancet 2023 Feb 25;401(10377)645-654, Y Wang, S Li, Y Pan, H Li, MW Parsons, BCV Campbell, LH Schwamm, M Fisher, F Che, H Dai, D Li, R Li, J Wang, Y Wang, X Zhao, Z Li, H Zheng, Y Xiong, X MengFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.